Non-alcoholic faty liver disease and liver fibrosis score have an independent relationship with the presence of mitral annular calcification

Int J Cardiovasc Imaging. 2023 Aug;39(8):1431-1436. doi: 10.1007/s10554-023-02858-2. Epub 2023 May 7.

Abstract

Non-alcoholic faty liver disease (NAFLD) and liver fibrosis score (FIB 4) are associated with increased mortality from cardiovascular causes. NAFLD and cardiac diseases are different manifestations of systemic metabolic syndrome. In this study, we aimed to reveal the relationship between NAFLD and FIB 4 liver fibrosis scores and mitral annular calcification (MAC). One hundred patients were included in the study. Blood samples and echocardiography measurements were obtained from each subject. The two groups were compared in terms of demographic and echocardiographic characteristics. Thirty-one men and 69 women with a mean age of 48.6 ± 13.1 years were included in the analysis. The patients were divided into two groups as those with MAC (n = 26) and those without (n = 74). The baseline demographic and laboratory data for the two groups were compared. In the group with MAC (+) age, serum creatinine levels, FIB4 and NAFLD Scores; HL, DM rates, angiotensin converting enzyme (ACE) inhibitor and statin usage rates were higher, with statistical significance. NAFLD and FIB 4 liver fibrosis scores have an independent relationship with MAC.

Keywords: FIB 4; MAC; NAFLD-FS.

MeSH terms

  • Adult
  • Calcinosis* / pathology
  • Female
  • Heart Valve Diseases* / complications
  • Humans
  • Liver
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / diagnostic imaging
  • Male
  • Middle Aged
  • Mitral Valve / diagnostic imaging
  • Non-alcoholic Fatty Liver Disease* / complications
  • Non-alcoholic Fatty Liver Disease* / diagnostic imaging
  • Predictive Value of Tests